21 results on '"Matteo Piovella"'
Search Results
2. Inflammation management in ophthalmology: new evidences for cataract surgery and beyond
- Author
-
Matteo Piovella, Teresio Avitabile, Roberto Bellucci, Aldo Caporossi, Giorgio Marchini, Pasquale Troiano, and Pier Luigi Canonico
- Subjects
Bronfenac ,Cataract surgery ,Inflammation management ,NSAIDs ,Medicine - Abstract
Inflammation represents the manifestation of the host's vascular and cellular response to tissue damage, hypersensitivity of the immune system or autoimmunity. As soon as the damage is detected, the mechanisms of localization and removal of foreign substances and damaged tissues are triggered. This response is amplified by the activation of inflammatory cells and by the production of chemical mediators derived from arachidonic acid, vasoactive substances and cytokines. At the ocular level, among the different responses implemented by various inflammation mediators, the action of prostaglandins is mainly expressed in three ways: i) change of intraocular pressure; ii) induction of miosis; iii) increase of protein concentration in the aqueous humor. Ocular inflammation may continue long after the cessation of the initial cause and may also lead to serious consequences, including permanent vision reduction. For this reason, it is essential to establish a correct and effective therapeutic strategy, which allows to control inflammation, the symptoms and the clinical signs associated with it. This article therefore deals with therapeutic strategies to control inflammation, with a particular focus on the role of nonsteroidal anti-inflammatory drugs (NSAIDs) in cataract surgery.
- Published
- 2019
- Full Text
- View/download PDF
3. Guidelines and recommendations for the SARS-CoV-2 health emergency. Organization of ophthalmic consultations to avoid contact between healthy and asymptomatic contagious positive subjects
- Author
-
Emilio C. Campos, Carlo Signorelli, Sandro Vergani, Fabrizio Pregliasco, Matteo Piovella, Maurizio Buscemi, Pasquale Troiano, and Luigi Mele
- Subjects
Coronavirus disease 2019 (COVID-19) ,business.industry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,General Medicine ,Scientific literature ,medicine.disease ,Asymptomatic ,Clinical Practice ,03 medical and health sciences ,0302 clinical medicine ,Pandemic ,030221 ophthalmology & optometry ,Medicine ,030212 general & internal medicine ,Medical emergency ,medicine.symptom ,business - Abstract
The Italian Ophthalmological Society (SOI) has developed clinical practice guidelines for the care of ophthalmic patients during the coronavirus disease 2019 (COVID-19) pandemic. The aim of this document is to define guidelines that would help ophthalmologists in their clinical activities through the adoption of recommended procedures to avoid common organization and management of positive asymptomatic contagious patients and healthy people. They are based on data available in scientific literature and real clinical experience. The document underlines the unique nature of ophthalmology and its impact on people’s health and wellbeing, outlines minimal requirements to be able to perform ophthalmology procedures, discusses the use of disposable devices and materials and outlines the criteria to manage potentially contagious patients and healthy people.
- Published
- 2020
4. Comparison of two extended depth of focus intraocular lenses with a monofocal lens: a multi-centre randomised trial
- Author
-
Matteo Piovella, Philip Maier, Stephane Colonval, Thomas Reinhard, Eckart Bertelmann, David Salom, Tobias Brockmann, Javier Mendicute, Laszlo Kiraly, and Daniel Böhringer
- Subjects
Depth of focus ,medicine.medical_specialty ,Visual acuity ,genetic structures ,Pseudophakia ,medicine.medical_treatment ,media_common.quotation_subject ,Cataract, presbyopia ,Intraocular lens ,Defocus ,Prosthesis Design ,Refraction, Ocular ,EDOF ,Cataract ,Near visual acuity ,law.invention ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,0302 clinical medicine ,Lens Implantation, Intraocular ,law ,Ophthalmology ,0502 economics and business ,medicine ,Humans ,Contrast (vision) ,Prospective Studies ,media_common ,Lenses, Intraocular ,Depth Perception ,Extended depth of focus ,Phacoemulsification ,Monocular ,business.industry ,05 social sciences ,eye diseases ,Sensory Systems ,Lens (optics) ,Intraocular lenses ,030221 ophthalmology & optometry ,050211 marketing ,sense organs ,medicine.symptom ,Intermediate visual acuity ,business - Abstract
Purpose The AT LARA 829MP is a next-generation extended depth of focus (EDOF) intraocular lens (IOL) providing continuous vision over a range of distances. The aim of this prospective multi-centre randomised trial was to compare two EDOF IOLs and one monofocal IOL. Methods Cataract patients between 50 and 80 years were randomised for bilateral implantation with either the AT LARA 829MP (EDOF), the TECNIS Symfony (EDOF) or the CT ASPHINA 409MP (monofocal). Follow-up was at 1 to 2 weeks, 1 month and 4 to 6 months. Results A total of 211 patients were randomised and included in the final analysis. Monocular depth of focus was significantly better for AT LARA 829MP eyes compared with that for TECNIS Symfony at all thresholds (p = 0.024, 0.001 and 0.006, for 0.1, 0.2 and 0.3 logMAR respectively) with no significant difference for binocular depth of focus. LARA eyes had significantly better monocular depth of focus at all levels compared with ASPHINA eyes (all p p p = 0.002). Distance visual acuity was similar for all IOLs at 6 months; intermediate and near visual acuity were significantly better for the EDOF IOLs than for the monofocal (p Conclusion The two EDOF intraocular lenses investigated provided good visual outcomes with comparable visual acuity at all distances. The AT LARA 829MP provided the widest monocular depth of focus at 0.1 and 0.2 logMAR, with a clear superiority compared with the monofocal IOL. TECNIS Symfony was superior to the monofocal control at 0.3 logMAR. Spectacle independence and patient satisfaction were comparable. Trial registration Trial registered on https://clinicaltrials.gov/ under the identification NCT03172351 (date of registration 1 June May 2017).
- Published
- 2020
5. Effectiveness of 0.66% Povidone-Iodine Eye Drops on Ocular Surface Flora before Cataract Surgery: A Nationwide Microbiological Study
- Author
-
Giovanni Alessio, Claudio Carbonara, Scipione Rossi, Matteo Piovella, Marianna Martinelli, Rosario Musumeci, Luisa Molteni, Claudio Giuseppe Molteni, Pasquale Troiano, Laura Saderi, Giovanni Sotgiu, Clementina Cocuzza, Musumeci, R, Troiano, P, Martinelli, M, Piovella, M, Carbonara, C, Rossi, S, Alessio, G, Molteni, L, Molteni, C, Saderi, L, Sotgiu, G, and Cocuzza, C
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Microbiological culture ,genetic structures ,medicine.drug_class ,medicine.medical_treatment ,Methicillin resistance ,Article ,03 medical and health sciences ,0302 clinical medicine ,Endophthalmitis ,Antiseptic ,Ophthalmology ,medicine ,Endophthalmiti ,povidone iodine ,business.industry ,General Medicine ,Perioperative ,Cataract surgery ,ocular surgery ,medicine.disease ,eye diseases ,030104 developmental biology ,endophthalmitis ,MED/07 - MICROBIOLOGIA E MICROBIOLOGIA CLINICA ,cataract ,030221 ophthalmology & optometry ,antiseptic prophylactic treatment ,Medicine ,sense organs ,business ,Ocular surface ,After treatment - Abstract
A multicenter, nonrandomized, prospective, controlled study was conducted to evaluate, as perioperative prophylactic treatment, the anti-infective effectiveness of 0.66% povidone-iodine eye drops (IODIM®) against the bacterial flora of the conjunctival surface of patients who undergo cataract surgery. Eye drops containing 0.66% povidone-iodine were applied to the eye undergoing cataract surgery, the untreated contralateral eye was used as control. One hundred and twenty patients set to receive unilateral cataract surgery were enrolled in 5 Italian Ophthalmology Centers and pretreated for three days with 0.66% povidone-iodine eye drops. The contralateral eye, used as control, was left untreated. Conjunctival swabs of both eyes were collected at the baseline visit and after three days of treatment, just before the cataract surgery. A qualitative and quantitative microbiological analysis of bacterial presence was evaluated by means of bacterial culture, followed by identification. Methicillin resistance determination was also performed on staphylococci isolates. Bacterial load before and after treatment of the eye candidate for cataract surgery was evaluated and compared to the untreated eye. A reduction or no regrowth on the culture media of the bacterial load was observed in 100% of the study subjects. A great heterogenicity of bacterial species was found. The 0.66% povidone-iodine eye drops, used for three days prior to cataract surgery, were effective in reducing the conjunctival bacterial load. The 0.66% povidone-iodine eye drops (IODIM®) might represent a valid perioperative prophylactic antiseptic adjuvant treatment to protect the ocular surface from microbial contamination in preparation of the surgical procedure.
- Published
- 2021
- Full Text
- View/download PDF
6. Prospective multicenter trial of a small-aperture intraocular lens in cataract surgery
- Author
-
Matteo Piovella, Clinical Investigators, H. Burkhard Dick, John A. Vukich, Srividhya Vilupuru, and Ling Lin
- Subjects
medicine.medical_specialty ,Visual acuity ,Pseudophakia ,genetic structures ,medicine.medical_treatment ,media_common.quotation_subject ,Visual Acuity ,Intraocular lens ,Cataract Extraction ,Astigmatism ,Prosthesis Design ,Contrast Sensitivity ,03 medical and health sciences ,0302 clinical medicine ,Lens Implantation, Intraocular ,Ophthalmology ,Lens, Crystalline ,Humans ,Medicine ,Contrast (vision) ,Dioptre ,media_common ,Lenses, Intraocular ,Phacoemulsification ,business.industry ,Cataract surgery ,medicine.disease ,eye diseases ,Sensory Systems ,Patient Satisfaction ,030221 ophthalmology & optometry ,Optometry ,Surgery ,sense organs ,medicine.symptom ,business ,030217 neurology & neurosurgery - Abstract
Purpose To evaluate the clinical acceptability of monocular implantation of the small-aperture (IC-8) intraocular lens (IOL) in 1 eye and an aspheric monofocal IOL in the fellow eye of bilateral cataract patients over 6 months postoperatively. Setting Twelve clinics in Austria, Belgium, Germany, Italy, Spain, and Norway. Design Prospective case series. Methods The visual acuity, depth of focus, contrast sensitivity, patient satisfaction, visual symptoms, and adverse events were assessed in patients who had bilateral cataract surgery followed by implantation of the small-aperture IOL in 1 eye and an aspheric monofocal IOL in the fellow eye. Uncorrected distance (UDVA), intermediate (UIVA), and near (UNVA) visual acuities were reported in Snellen notation. Results The study comprised 105 patients. At 6 months, the UDVA, UIVA, and UNVA in eyes with the small-aperture IOL were 20/23, 20/24, and 20/30, respectively. Ninety-nine percent, 95%, and 79% of patients achieved 20/32 or better binocular UDVA, UIVA, and UNVA, respectively. Ninety-three patients (95.9%) reported they would have the procedure again versus 4 patients (4.1%) who reported they would not have the procedure again. In eyes with the small-aperture IOL, the target-corrected defocus curve measured with 0.75 diopter (D) of myopia extended the range of functional near vision by an additional diopter without loss of distance vision compared with the distance-corrected defocus curves. The mean UIVA and UNVA remained at 20/25 and 20/32, respectively, for up to 1.5 D of residual astigmatism in eyes with the small-aperture IOL. Conclusion The small-aperture IOL showed excellent visual performance, safety, patient satisfaction, and tolerance to residual astigmatism 6 months after implantation.
- Published
- 2017
7. [Inflammation management in ophthalmology: new evidences for cataract surgery and beyond]. La gestione dell’infiammazione in oftalmologia: nuove evidenze per la chirurgia della cataratta e oltre
- Author
-
Matteo Piovella, Aldo Caporossi, Teresio Avitabile, Giorgio Marchini, Pier Luigi Canonico, Roberto Bellucci, and Pasquale Troiano
- Subjects
Miosis ,Intraocular pressure ,NSAIDs ,medicine.medical_treatment ,Inflammation ,medicine.disease_cause ,Cataract surgery ,Autoimmunity ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Immune system ,Vasoactive ,medicine ,030212 general & internal medicine ,business.industry ,Inflammation management ,General Medicine ,Bronfenac ,Bronfenac, Cataract surgery, Inflammation management, NSAIDs ,chemistry ,Immunology ,030221 ophthalmology & optometry ,Arachidonic acid ,medicine.symptom ,business - Abstract
Inflammation represents the manifestation of the host's vascular and cellular response to tissue damage, hypersensitivity of the immune system or autoimmunity. As soon as the damage is detected, the mechanisms of localization and removal of foreign substances and damaged tissues are triggered. This response is amplified by the activation of inflammatory cells and by the production of chemical mediators derived from arachidonic acid, vasoactive substances and cytokines.At the ocular level, among the different responses implemented by various inflammation mediators, the action of prostaglandins is mainly expressed in three ways: i) change of intraocular pressure; ii) induction of miosis; iii) increase of protein concentration in the aqueous humor.Ocular inflammation may continue long after the cessation of the initial cause and may also lead to serious consequences, including permanent vision reduction. For this reason, it is essential to establish a correct and effective therapeutic strategy, which allows to control inflammation, the symptoms and the clinical signs associated with it.This article therefore deals with therapeutic strategies to control inflammation, with a particular focus on the role of nonsteroidal anti-inflammatory drugs (NSAIDs) in cataract surgery.
- Published
- 2019
8. August consultation #8
- Author
-
Matteo Piovella
- Subjects
Ophthalmology ,Surgery ,Sensory Systems - Published
- 2016
9. Clinical evaluation of the OptiVis™ multifocal intraocular lens
- Author
-
Matteo Piovella and Jean-Michel Bosc
- Subjects
Male ,medicine.medical_specialty ,Visual acuity ,Pseudophakia ,genetic structures ,media_common.quotation_subject ,medicine.medical_treatment ,Contrast Sensitivity ,Lens Implantation, Intraocular ,Ophthalmology ,Product Surveillance, Postmarketing ,medicine ,Humans ,Contrast (vision) ,Pharmacology (medical) ,Macular edema ,Aged ,Monitoring, Physiologic ,media_common ,Medicine(all) ,Lenses, Intraocular ,Postoperative Care ,Phacoemulsification ,business.industry ,Extracapsular extraction ,Glare (vision) ,General Medicine ,Middle Aged ,Multifocal intraocular lens ,medicine.disease ,eye diseases ,Clinical trial ,Treatment Outcome ,Patient Satisfaction ,Female ,sense organs ,medicine.symptom ,business - Abstract
The purpose of this study was to evaluate the efficacy of the OptiVis™ Multifocal Intraocular Lens (IOL) in patients undergoing bilateral crystalline lens replacement following extracapsular extraction by phacoemulsification.This was a prospective 6-month, open-label, nonrandomized clinical trial of subjects undergoing bilateral implantation with the OptiVis Multifocal IOL. Of the 121 eyes enrolled, 88 eyes of 44 subjects completed the entire 6-month trial.After 6 months, the majority of eyes had a distance best-corrected visual acuity of 20/20 or better, with 89.8% achieving that outcome, and 100% with 20/32 or better. At an intermediate distance, most eyes (90.9%) had a distance corrected intermediate visual acuity of 20/40 or better, and 53.4% had an acuity of 20/32 or better. At a near distance, most eyes (95.5%) had a distance corrected near visual acuity of 20/40 or better by month 6. The most commonly reported adverse event was mild-to-moderate halos (n = 30, 36%) and mild-to-moderate glare (n = 15, 18%). In addition, there was one case of cystoid macular edema, one posterior capsular opacification, and one case of severe corneal edema. Postoperative contrast sensitivity was comparable with normal phakic subjects ≥ 60 years of age.The OptiVis Multifocal IOL provided satisfactory visual acuity at distance, near, and intermediate with no apparent reduction in contrast sensitivity. Additional, longer-term follow-up studies are planned.
- Published
- 2011
10. Rapid Assessment Of Risk For Age-related Macular Degeneration: The Stars Questionnaire
- Author
-
Battaglia Parodi M, Cecile DelCourt, Matteo Piovella, Cattaneo Giampiero, and Francesco Bandello, Battaglia Parodi M, Battaglia Parodi, M, Cecile, Delcourt, Matteo, Piovella, Cattaneo, Giampiero, and Bandello, Francesco
- Abstract
Purpose To describe a short questionnaire for a rapid assessment of risk factors for AMD, and assess its feasibility and relevance in a large-scale Italian study. Methods Risk factors having shown the most consistent associations with AMD in the literature were included in the STARS (Simplified Théa AMD Risk-assessment Scale) questionnaire, which was designed to be simple, quick and easy to fill in. Its feasibility and relevance were assessed in an Italian nationwide study. Between May and September 2010, all patients of both genders, aged 55 years or more, consulting the participating ophthalmologists during one week of consultations, were invited to take part in the study. Items on demography, medical history, and lifestyle were filled in by the patient. The ophthalmologist then performed the eye examinatio,and filled in the second part of the questionnaire (iris colour, cataract extraction, refraction, AMD classification). Patients affected by soft drusen and/or pigmentary abnormalities were classified as early AMD, whereas patients affected by geographic atrophy and/or neovascular AMD were classified as late AMD. Subjects with early and late AMD were compared to those without AMD using polytomous nominal logistic regression. Results One hundred and seventy-seven ophthalmologists prospectively recruited 12,639 subjects. Overall, 6061 (48.0%) were affected by early AMD, 1483 (11.7%) by late AMD, whereas 5095 (40.3%) were not affected by AMD. In the final multivariate model, age, female gender, North-African origin, family history of AMD, smoking, obesity, history of cardiovascular diseases,cataract surgery, myopia, hyperopia, living in a sunny area and usual solar protection were significantly associated with increased risk for both early and late AMD. High fruit consumption was associated with a significantly decreased risk for early and late AMD, while consumption of green vegetables and fish were not significantly associated with early or late AMD.Consumption of alcohol (beer or wine) and clear iris wereassociated with increased risk for early but not late AMD. Conclusions The STARS questionnaire can easily be implemented in the practice of ophthalmologists. It may prove useful as a screening tool, after improvement and further validation.
- Published
- 2012
11. Excimer Laser Photorefractive Keratectomy for High Myopia
- Author
-
Cesare Fattori, Fabrizio I. Camesasca, and Matteo Piovella
- Subjects
Refractive error ,medicine.medical_specialty ,Visual acuity ,genetic structures ,business.industry ,medicine.medical_treatment ,Eye disease ,Emmetropia ,medicine.disease ,eye diseases ,Photorefractive keratectomy ,Vision disorder ,Ophthalmology ,Medicine ,Severe Myopia ,sense organs ,medicine.symptom ,business ,Dioptre - Abstract
Purpose: The purpose of the study is to evaluate the results of the authors' 4-year experience with excimer laser photorefractive keratectomy (PRK) and multiple optical zone corneal ablation in highly myopic eyes. Methods: The authors retrospectively evaluated 56 eyes of 44 patients (mean refraction, −11.3 diopters [D]; range, −5.75 to −24.5 D) who underwent PRK with a Visx Model 20/20 laser (Visx, Santa Clara, CA). Preoperative visual acuity of 20/40 or better was present in 46 eyes. Corneal ablation was divided into concentric optical zones (4, 5, and 6 mm), allowing corrections of up to 18 D, with a refractive goal of within −1 D from emmetropia in 49 eyes. A hand-held fixation system was always used, and a nitrogen-blowing system (NBS) was used in the first 21 eyes only. Results: Before retreatment, the range of final cycloplegic refraction from emmetropia in eyes treated with NBS versus not was within ±1 D in 6 (28.6%) and 15 eyes (44.1%), between −1.25 and −3 D in 5 (23.8%) and 14 eyes (41.1%), and more than −3 D in 10 (47.6%) and 5 eyes (14.7%), respectively. No lines of visual acuity were lost in 37 eyes (80.4%) with 20/40 or better visual acuity before surgery. Three eyes showed vision loss due to worsening of myopic maculopathy and one due to corneal haze. Correction stabilized within 9 months, and at a mean time of 25.6 months, the correction attained was of −8.5 ± 3.6 D, achieving 90.3% of attempted correction. Eyes with preoperative myopia less than −10 D (n = 27) showed regression less than −1 D in 8 eyes (29.6%), between −1.25 and −3.00 D in 5 eyes (18.5%), and greater than −3.00 D in 1 eye (3.7%); eyes with more than −10 D (n = 29) regressed in 3 (10.3%), 6 (20.7%), and 1 eye (3.4%), respectively. Severe haze was observed in 11 eyes (19.6%) 3 months after surgery. Two eyes showed decentration greater than 1.5 mm. At last examination, night driving problems were reported by 12 (41.4%) of 29 patients evaluated who drive. Conclusions: After the NBS was eliminated, the multiple-zone technique achieved a long-term, stable 83.1 % reduction of preoperative myopia. Patients with severe myopia appreciated reduction of most of the refractive defect, although perception of halos was noted by 16 patients.
- Published
- 1997
12. Contributors
- Author
-
Timothy J. Archer, Harkaran S. Bains, Michael Bergt, FabrizioI. Camesasca, James Copland, Richard S. Davidson, Sheraz M. Daya, Diego de Ortueta, H. Burkhard Dick, Marcela Espinosa-Lagana, I. Howard Fine, Jens Flügge, Jack C. Griffis, Richard S. Hoffman, Simon Holland, Ronald R. Krueger, Barbara Kusa, C. David Lin, Thomas Magnago, Zoltán Z. Nagy, Daniel R. Neal, Mark Packer, Matteo Piovella, Mihai Pop, Tarak Pujara, Dan Z. Reinstein, Eckhard Schroeder, Gustavo E. Tamayo, Michael J. Taravella, Scott A. Thomas, Daniel M. Topa, Hartmut Vogelsang, and Gene W. Zdenek
- Published
- 2008
13. Katana LaserSoft: a solid-state laser for refractive surgery
- Author
-
Matteo Piovella, Fabrizio I. Camesasca, and Barbara Kusa
- Subjects
Materials science ,Optics ,Solid-state laser ,business.industry ,Refractive surgery ,medicine.medical_treatment ,medicine ,business - Published
- 2008
14. Phakodynamics of Microincision Phako
- Author
-
Matteo Piovella
- Subjects
Materials science ,business.industry ,law ,Refractive surgery ,medicine.medical_treatment ,Solid-state ,medicine ,Optoelectronics ,business ,Laser ,law.invention - Published
- 2007
15. Mastering the Techniques of Corneal Refractive Surgery
- Author
-
E Hoyos Jairo, G Pallikaris Ioannis, Roberto Pinelli, Matteo Piovella, Ashok Garg, K Mehta Cyres, and Guillrmo Avalos-Urzua
- Subjects
medicine.medical_specialty ,business.industry ,Ophthalmology ,Refractive surgery ,medicine.medical_treatment ,medicine ,business - Published
- 2006
16. Solid-State Lasers for Refractive Surgery
- Author
-
Fabrizio Camesasca, Matteo Piovella, and Barbara Kusa
- Subjects
Materials science ,law ,business.industry ,Refractive surgery ,medicine.medical_treatment ,Solid-state ,medicine ,Optoelectronics ,Laser ,business ,law.invention - Published
- 2006
17. Mastering the Techniques of Presbyopia Surgery
- Author
-
E Hoyos Jairo, Roberto Pinelli, Ashok Garg, Matteo Piovella, R Mehta Keiki, and Avalos Urzua Guillermo
- Subjects
business.industry ,Medicine ,Optometry ,Presbyopia ,business ,medicine.disease - Published
- 2006
18. Refractive, Endothelial and Aberrometric Follow-up of Foldable Anterior Chamber Phakic IOL (Vivarte)
- Author
-
Matteo Piovella, Barbara Kusa, and Faberizio Camesasca
- Subjects
medicine.medical_specialty ,Materials science ,Ophthalmology ,medicine ,Phakic iol - Published
- 2005
19. Cataract surgical problem: Reply
- Author
-
Matteo Piovella and Fabrizio I. Camesasca
- Subjects
Ophthalmology ,Surgery ,Sensory Systems - Published
- 2003
20. Cataract surgical problem: Reply #A
- Author
-
Matteo Piovella and Fabrizio I. Camesasca
- Subjects
Ophthalmology ,medicine.medical_specialty ,Family medicine ,medicine ,Surgery ,Sensory Systems - Published
- 2002
21. Lenti intraoculari filtranti
- Author
-
CILLINO, Salvatore, Castellucci, M., Novara, C., Coordinatori: Roberto Bellucci, Matteo Piovella, Scipione Rossi, Giorgio Tassinari, Pasquale Troiano, Giovanni Alessio Direttore Clinica Oculistica, Dipartimento di Scienze mediche di base, Neuroscienze e Organi di senso, Università Degli Studi di Bari Alberto Amisano Oculista Struttura Complessa di Oculistica - Ospedale San Bassiano di Bassano del Grappa Ilir Arapi The Eye Clinic, University of Medicine di Tirana Paolo Arpa U.O. Oculistica Ospedale San Gerardo di Monza Teresio Avitabile Clinica Oculistica dell’Università degli Studi di Catania Marco Azzolini U.O. Oculistica Ospedale San Gerardo di Monza Antonio Baldascino Istituto di Oftalmologia, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario 'A. Gemelli' di Roma Nicole Balducci Studio Oculistico d’Azeglio di Bologna Alessia Baitieri Ortottista, UO Oculistica ICVA ‘Villa Aprica’ (CO) Piero Barboni Studio Oculistico d’Azeglio, Bologna, Istituto Scientifi co San Raffaele, Milano Antonio Bardocci Divisione Oculistica, Ospedale San Pietro – Fatebenefratelli di Roma Federico Basilico Istituto di Oftalmologia 'F. Trimarchi' - Unità Operativa di Oculistica Ospedale Fatebenefratelli 'Sacra Famiglia' di Erba Giorgio Beltrame Direttore Azienda per l’Assistenza Sanitaria n. 5 'Friuli Occidentale' - Presidio Ospedaliero di Pordenone - Dipartimento di Chirurgica Specialistica - S.C. di Oculistica Francesca Bertuzzi Clinica Oculistica del Policlinico di Monza, Università Milano-Bicocca Davide Berzaghi Scuola di Specializzazione in Oftalmologia dell’Università di Verona. AOUI di Verona Costantino Bianchi Oftalmologo, Libero Professionista, Milano Mario Bifani Dipartimento Multidisciplinare di Specialità Medico Chirurgiche ed Odo Tiziana Boccia Dipartimento Multidisciplinare di Specialità Medico Chirurgiche ed Odontoiatriche, Oftalmologia. Seconda Università degli Studi di Napoli Domenico Boccuzzi Clinica Mediterranea di Napoli Vincenza Bonfi glio Clinica Oculistica dell’Università degli Studi di Catania Alessandra Brancaleoni Oculista presso AUSL di Rimini Giacomo Calzetti Clinica oculistica universitaria di Parma Massimo Camellin Direttore Sanitario SEKAL Microchirurgia Oculare, Rovigo Fabrizio Camesasca Unità Operativa di Oculistica Humanitas Research Hospital Rozzano, Milano Luca Campi Struttura Complessa di Oftalmologia, Azienda Ospedaliero Universitaria Policlinico di Modena, Università degli Studi di Modena Emilio C. Campos Oftalmologia Universitaria, DIMES., Alma Mater Studiorum University of Bologna e AOU S.Orsola-Malpighi di Bologna Aldo Caporossi Direttore Istituto di Oftalmologia, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario 'A. Gemelli' di Roma Luca Cappuccini Direttore presso AUSL di Rimini Guido Caramello Primario di Oculistica - Ospedale Santa Croce e Carle di Cuneo Claudio Carbonara Studio Oculistico Carbonara, Roma Miriam Cargnoni Oculistica A - Dipartimento di Neuroscienze - Azienda Ospedaliera Universitaria Integrata di Verona Fulvio Carraro Primario UOC Oculistica Ospedale San Giuseppe di Empoli Massimo Castellucci Università degli Studi di Palermo - Scuola di Medicina e Chirurgia - Dipartimento di Biomedicina Sperimentale e Neuroscienze Cliniche - Sezione di Oftalmologia, Cillino, S., Castellucci, M., and Novara, C.
- Subjects
Settore MED/30 - Malattie Apparato Visivo ,Lenti intraoculari ,cataratta, miols - Abstract
Relazione e stato dell'arte sulle lenti intraoculari filtranti
- Published
- 2015
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.